Severna Park, Maryland-based mobile sleep apnea-focused company Appian Medical has raised $580,000 from angel investors to conduct validation studies and apply for FDA 510(k) clearance for its app.
Appian CEO Michael Thomas told MobiHealthNews they are also starting talks with investors to raise their series A funding round. Thomas was formerly the CEO of asthma monitoring company iSonea.
Appian...
